je.st
news
Tag: ebola
Ebola vaccine results 'hugely important' in tackling epidemic
2015-07-31 18:05:13| Biotech - Topix.net
An end to the Ebola epidemic in West Africa may be in sight after results from a fast-tracked vaccine trial were described as "hugely important" and "very exciting" by experts. The experimental vaccine VSV-ZEBOV was found to be 100% effective six days after it was administered to 7,651 people living in Guinea, where the virus has already claimed more than 2,500 lives.
Tags: results
important
vaccine
epidemic
In Interim Results from Phase 3 Study, Mercks Investigational Ebola Vaccine Efficacious; Study is Continuing
2015-07-31 14:10:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Global Collaboration Enabled Vaccine to Move from First-in-Human Studies to Initial Phase 3 Results Within One Year KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (known as MSD outside the US and Canada) said today that its investigational Ebola vaccine candidate, rVSV-ZEBOV, was found to have 100 percent efficacy in an analysis of interim data from a Phase 3 ring vaccination trial in Guinea. Preliminary conclusions from this study, which is continuing, were published on-line today in The Lancet. Language: English Contact: MerckMedia Contacts:Pam Eisele, 267-305-3558orInvestor Contacts:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Ebola screening relaxed at Birmingham and Manchester airports
2015-07-24 13:10:00| Airport Technology
The Public Health England (PHE) has relaxed screening for Ebola at West Africa to Birmingham and Manchester airports.
Tags: screening
manchester
birmingham
airports
Emergent BioSolutions manufacturing Ebola treatment in Baltimore
2015-07-20 17:36:33| Biotech - Topix.net
Gaithersburg biotechnology company Emergent BioSolutions will make a treatment for the Ebola virus at its East Baltimore manufacturing facility, the company said Monday. The defense department's Biomedical Advanced Research and Development Authority is paying Emergent $19.7 million to manufacture Ebola monoclonal antibodies.
Tags: treatment
manufacturing
baltimore
emergent
Oxford University performs second phase of experimental Ebola vaccine trial
2015-07-15 18:58:50| Biotech - Topix.net
Oxford University doctors and scientists are performing the second phase of clinical studies of an experimental Ebola vaccine regimen. The study is part of the EBOVAC2 project, a collaborative programme involving the University of Oxford, French Institute of Health and Medical Research as project coordinator, London School of Hygiene & Tropical Medicine , Le Centre Muraz , Inserm Transfert and the Janssen Pharmaceutical Companies of Johnson & Johnson .
Tags: university
trial
phase
experimental
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] next »